FREQUENCY OF VACCINATION IN CHILDREN WITH MEASLES

Tariq Ayub, Fariha -, Sami Ul Haq, Ihsan Ullah

Abstract


Background: Measles is a highly contagious infection caused by single stranded RNA Paramyxo virus. Humans are the only natural host. Epidemics of the disease may occur. Measles vaccination is important for its prevention. The objective of this study was to find out the frequency of vaccination in children suffering from measles.
Materials & Methods: This cross-sectional descriptive study was conducted in Paediatric Unit of Women and Children Teaching Hospital, Bannu Medical College, Bannu, from November 2014 to February 2015. One hundred children with measles were taken both from indoor and outdoor patients department. Both males and females up to 15 years of age were included in the study. Clinical record along with vaccination status was recorded. The data was analyzed.
Results: Among 100 children, 2(2%) were under 6 months and were all males. Age group 6 months to one year included 17(17%) males and 11(11%) females. Among the age group 1-5 years, 40(40%) were males and 21(21 %) females. Age group 5-15 years included 7(7%) males and 2(2%) females. Total number of males was 66(66%) and females were 34(34%) with male to female ratio was 1.9:1. Among 100 children suffering from measles, only 7(7%) were vaccinated and 93(93%) were un-vaccinated.
Conclusion: Measles is common in un-vaccinated children. It is strongly recommended that all the children should be vaccinated against measles.

Keywords


Measles; Vaccination; Immunization.

Full Text:

PDF

References


Marcdante KJ, Kliegman RM. Infection characterized by fever and rash: Measles (Rubeola). Nelson Essentials of Pediatrics. 2015; 7:329-31.

Brown DWG, Ramsay MEB, Richards AF. Salivary diagnosis of measles: a study of notified cases in the United Kingdom. BMJ 1994; 308:1991-3.

Miller E, Nokes DJ, Anderson RM. Mea¬sles, mumps, and rubella vaccination. BMJ 1992;304:1440–1.

Aaby P, Bukh J, Lisse IM, Smits AJ. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau J Infect 1984;8:13–21.

Aaby P, Andersen M, Sodemann, Jakobsen M, Gomes J, Fernandes M. Reduced childhood mortality following standard measles vaccination at 4–8 months compared to 9–11 months of age. BMJ 1993;307:1308–11.

Clemens JD, Stanton BF, Chakraborty J, Chowdhury S, Rao MR, Ali M, et al. Measles vaccination and childhood mortality in rural Bangladesh. Am J Epidemiol 1988;128:1330–9.

Wakefield AJ, Murch SH, Anthony A, Linell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637–41.

Kaye JA. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis BMJ 2001;322:460-5.

Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot M , Li J, et al. Autism and measles, mumps, and rubella vaccine: no epidemiolog¬ical evidence for a causal association. Lancet 1999;353:2026–9.

Zhou F, Shefer A, Wenger J, Messonier M, Wang LY, Lopez A, et al. Economic evaluation of the routine childhood immunization program in the United States. Pediatrics 201;133:577-85.

Fourth report to the Medical Research Council by the Measles Sub-Committee on development of vaccines and immunisation procedures. Lancet 1977;ii:571–5.

Hawe P, Wilson A, Fahey P, Field P, Cunnigham AL, Baker M, et al. The validity of parental report of vaccination as a measure of a child’s measles immunisation status. The Med J Australia 1991;155:684-6.

Siedler A, Tischer A, Mankertz A, Santibanez S. Two outbreaks of measles in Germany. Euro Surveill 2006;11:131-4.

Paunio M, Peltola H, Valle M, Davidkin I, Virtanen M, Heinonen OP. Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine. J Epidemiol Community Health 1999;53:173-8.

Krugman S. Further-attenuated measles vaccine: characteristics and us. Rev Infect Dis 1983;5: 477-81.

Bottiger M, Forsgren M. Twenty years experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination. Vaccine 1997;15:1538-44.

Aaby P, Knudsen K, Jensen TG, Thaarup J, Poulsen A, Sodemann M, et al. Measles inci¬dence, vaccine efficacy and mortality in two urban African areas with high vaccination coverage. Infect Dis 1990;162:1043–8.

Koenig MA, Khan MA, Wojtyniak B, Clemens JD, Chakraborty J, Fauveau V, et al. The impact of measles vaccination upon childhood mortality in Matlab, Bangladesh. Bull World Health Organ 1990;68:441–7.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Tariq Ayub, Fariha -, Sami Ul Haq, Ihsan Ullah

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.